HB 333 Utah House · 2025 General Session

Medications in Schools Amendments

HB 333 amends Utah law to allow students with severe allergies to possess and self-administer epinephrine nasal spray at school under specific conditions, directly affecting students with anaphylaxis. The bill updates definitions in school health codes to include "epinephrine nasal spray" as a permitted medication, distinguishing it from injectable forms. Key provisions clarify that schools must permit student self-administration of this nasal spray type during allergic reactions, while maintaining requirements for trained staff. This change expands access to emergency allergy treatment without requiring a school nurse's direct involvement in all cases.
Bill status signed all 5 stages cleared
Introduction
Jan 2025
Committee Review
Feb 2025
House Passage
Mar 2025
Senate Passage
Feb 2025
Signed into Law
Mar 2025
Introduced Jan 27, 2025 Signed Mar 24, 2025
Maddy AI version diff · 3 comparisons

What changed between versions

Substitute #2 Enrolled · 4 edits · Mar 24, 2025
MODERATE
This bill updates the Utah Code to clarify definitions and procedures for managing epinephrine and asthma medication in schools. It adds a specific definition for 'epinephrine nasal spray' and expands the rules allowing students to possess and self-administer this specific device. The changes also refine training requirements and liability protections for qualified adults and schools.
Scope change
The bill's scope remains focused on school safety and medical emergency protocols, but it now explicitly includes epinephrine nasal spray as a permitted device for student possession and self-administration under certain conditions.
DEFINITION

Added a new definition for 'epinephrine nasal spray' to distinguish it from injectable auto-injectors.

Added a new definition for 'qualified injectable epinephrine auto-injectorrescue medication entity' to clarify which organizations must store these devices.

ELIGIBILITY

Modified Section 26B-4-407 to explicitly allow public schools to permit students to possess and self-administer epinephrine nasal spray with parental and medical authorization.

TECHNICAL

Corrected formatting errors where section numbers were merged with text (e.g., '1818 years old' changed to '18 years old').

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
42
Key actions
8
Committee
5
Amendments
2
Mar 24, 2025
Signed into law
Governor Signed
executive
Mar 8, 2025
Legislature · Passed
House/ signed by Speaker/ sent for enrolling
legislature
Mar 8, 2025
Lower · Passed
Senate/ signed by President/ returned to House
lower
Mar 7, 2025
Upper · Passed
House/ concurs with Senate amendment
upper
Mar 7, 2025
Introduced
Senate/ to House with amendments
lower
Feb 27, 2025
Upper · Passed
Senate/ committee report favorable
upper
Feb 26, 2025
Upper · Passed
Senate Comm - Favorable Recommendation
upper
Feb 24, 2025
Committee
Senate/ to standing committee
upper
Feb 14, 2025
Introduced
Senate/ 1st reading (Introduced)
upper
Feb 13, 2025
Upper · Passed
House/ passed 3rd reading
upper
Feb 10, 2025
Lower · Passed
House Comm - Favorable Recommendation
lower
Feb 5, 2025
Committee
House/ to standing committee
lower
Jan 27, 2025
Introduced
House/ 1st reading (Introduced)
lower
1 primary · 1 co-sponsor

Sponsors